TrialThe Journal of allergy and clinical immunology2023

Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.

Ayobami T Akenroye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.